Author

Nikos Viazis

TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE
TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE

Nikos Viazis  et al.

THE NATURAL HISTORY OF COVID-19 IN VACCINATED INFLAMMATORY BOWEL DISEASE PATIENTS
THE NATURAL HISTORY OF COVID-19 IN VACCINATED INFLAMMATORY BOWEL DISEASE PATIENTS

Nikos Viazis  et al.

AN ELUSIVE MANIFESTATION OF COVID-19: DYSPHAGIA DUE TO ESOPHAGO-GASTRIC JUNCTION DISORDERS
AN ELUSIVE MANIFESTATION OF COVID-19: DYSPHAGIA DUE TO ESOPHAGO-GASTRIC JUNCTION DISORDERS

Nikos Viazis  et al.

THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB
THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB

Nikos Viazis  et al.

THE INFLAMMATORY BOWEL DISEASE – DISK TOOL FOR ASSESSING DISABILITY IN INFLAMMATORY BOWEL DISEASE PATIENTS: VALIDATION OF THE GREEK VERSION
THE INFLAMMATORY BOWEL DISEASE – DISK TOOL FOR ASSESSING DISABILITY IN INFLAMMATORY BOWEL DISEASE PATIENTS: VALIDATION OF THE GREEK VERSION

Nikos Viazis  et al.

COMPROMISED PERFORMANCE OF LUGOL CHROMOENDOSCOPY AND ASSOCIATED ENDOSCOPIC PATTERNS IN PATIENTS WITH ADVANCED ACHALASIA
COMPROMISED PERFORMANCE OF LUGOL CHROMOENDOSCOPY AND ASSOCIATED ENDOSCOPIC PATTERNS IN PATIENTS WITH ADVANCED ACHALASIA

Nikos Viazis  et al.

THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD
THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD

Nikos Viazis  et al.

Item 1 - 7 / 7
1